Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046102

Options or other derivatives

  • SVP & Chief Medical Officer acquired 533,710 shares (grant or award)
  • SVP & Chief Medical Officer returned 533,710 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Galimi Francesco · SVP & Chief Medical Officer

Table II: Derivative

12 lines
Date Transaction Shares Owned after D/I
2023-08-14 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −113,652 0 D
2023-08-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +113,652 113,652 D
2023-08-14 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −77,269 0 D
2023-08-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +77,269 77,269 D
2023-08-14 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −73,964 0 D
2023-08-14 Grant or award : show line 6 in the form Stock Option (Right to Buy) +73,964 73,964 D
2023-08-14 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −26,625 0 D
2023-08-14 Grant or award : show line 8 in the form Stock Option (Right to Buy) +26,625 26,625 D
Loading xslF345X05/doc4.xml…